<!-- Removed from chapter12.10-physiological-waveform-analysis.md by honest_takes.py. Restore with: python3 honest_takes.py --restore -->

## The Honest Take

Here's what nobody tells you about building real-time waveform analysis systems:

The ML model is maybe 20% of the work. The other 80% is plumbing: getting data out of medical devices (which speak arcane protocols and have terrible documentation), handling the constant stream of artifact (which in a real ICU is relentless), building alert suppression logic that clinicians actually trust, and integrating with clinical workflows that were designed around human observation, not algorithmic notification.

Alert fatigue will kill your project faster than bad model accuracy. I've seen systems with 95% sensitivity get turned off because the 5% false positive rate, applied to continuous monitoring of 30 patients, generated dozens of spurious alerts per shift. Nurses will disable your system. They will find the power button. Design for specificity first, sensitivity second.

The signal quality problem is worse than you think. Academic papers report results on curated datasets where artifact has been manually removed. In a real ICU, you'll lose 20-40% of your data to quality rejection. That's not a bug; that's reality. Plan for it. Your system needs to gracefully degrade when signal quality drops, not silently produce garbage.

Device integration is a nightmare. Every monitor vendor has a different protocol, a different data format, and a different idea of what "real-time" means. Some devices buffer internally and dump data in bursts. Some have proprietary APIs that require vendor partnerships to access. Budget 3-6 months just for the device integration layer, and that's if you have experience with medical device interoperability.

The FDA question looms over everything. If your system makes diagnostic claims ("this patient has atrial fibrillation"), it's a medical device and needs FDA clearance. If it makes advisory claims ("this patient's rhythm has changed; clinician review recommended"), the regulatory path may be lighter but is not absent. Get regulatory counsel involved early. The difference between a cleared device and an unapproved one is not technical; it's legal.

---

